Most start-ups wouldn’t employ the strategy that PostEra has. In fact, many of its business decisions seem counterintuitive. PostEra owns little to no intellectual property (IP) on its early work, ...
The July 1 quarterly HCPCS Level II update includes several drug/biological code changes, according to an AAPC release. Effective July 1, the HCPCS Level II code J7184 will be replaced with Q2041 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results